Abstract
New antibiotics are continuously required to combat antibiotic-resistant bacteria. This resistance increasingly limits the effectiveness of current antimicrobial drugs. Besides the problem of antibiotic resistance, new families of antibiotics are needed to enter the marketplace at regular intervals to face new diseases caused by evolving pathogens. Antibiotics toxicity is another reason for developing new antibiotics. Microorganisms are amazing producers of a great diversity of natural products including secondary metabolites. These metabolites constitute half of the pharmaceuticals on the market today and provide agriculture and livestock with many essential products. This chapter centers on the different approaches for searching new antibiotic-producing microorganisms with special emphasis in novel potential sources, bioprospecting, and new molecular tactics to look for novel compounds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anand S, Prasad MVR, Yadav G et al (2010) SBSPKS: structure based sequence analysis of polyketide synthases. Nucleic Acids Res 38:W487–W496. doi:10.1093/nar/gkq340
Ashour M, Wink M, Gershenzon J (2010) Biochemistry of plant secondary metabolism. Annu Plant Rev 40:258–303. doi:10.1002/9781444320503.ch5
Aziz R, Bartels D, Best A et al (2008) The RAST server: rapid annotations using subsystems technology. BMC Genom 9:75. doi:10.1186/1471-2164-9-75
Bachmann BO, Van Lanen SG, Baltz RH (2014) Microbial genome mining for accelerated natural products discovery: is a renaissance in the making? J Ind Microbiol Biotechnol 41:175–184. doi:10.1007/s10295-013-1389-9
Baker DD, Chu M, Oza U, Rajgarhia V (2007) The value of natural products to future pharmaceutical discovery. Nat Prod Rep 24:1225–1244. doi:10.1039/b602241n
Baker M (2011) Metabolomics: from small molecules to big ideas. Nat Meth 8:117–121. doi:10.1038/nmeth0211-117
Balzer S, Malde K, Lanzén A et al (2010) Characteristics of 454 pyrosequencing data-enabling realistic simulation with flowsim. Bioinformatics 26:1420–1425. doi:10.1093/bioinformatics/btq365
Banskota AH, Mcalpine JB, Sørensen D et al (2006) Isolation and identification of three new 5-alkenyl-3, 3 (2H)-furanones from two Streptomyces species using a genomic-screening approach. J Antibiot 59:168–176. doi:10.1038/ja.2006.24
Barry AL (2007) An overview of the Clinical and Laboratory Standards Institute (CLSI) and its impact on antimicrobial susceptibility tests. In: Schwalbe R, Steele-Moore L, Goodwin AC (eds) Antimicrobial susceptibility testing protocols. CRC Press. USA, pp 1–6. doi:10.1201/9781420014495.ch1
Barton HA (2006) Introduction to cave microbiology: a review for the non-specialist. J Cave Karst Stud 68(2):43–54
Bassetti M, Merelli M, Temperoni C, Astilean A (2013) New antibiotics for bad bugs: where are we? Annals Clin Microbiol Antimicrob 12:22. doi:10.1186/1476-0711-12-22
Bastian F, Jurado V, Nováková A, Alabouvette C, Saiz-Jimenez C (2010) The microbiology of Lascaux cave. Microbiology 156:644–652. doi:10.1099/mic.0.036160-0
Bauer AW, Kirby WM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496
Beatty JT, Overmann J, Lince MT, Manske AK et al (2005) An obligately photosynthetic bacterial anaerobe from a deep-sea hydrothermal vent. Proc Natl Acad Sci USA 2102:9306–9310. doi:10.1073/pnas.0503674102
Behnken S, Hertweck C (2012) Cryptic polyketide synthase genes in non-pathogenic Clostridium spp. PLoS ONE 7:e29609. doi:10.1371/journal.pone.0029609
Bennett JW (2015) Microorganisms producing antibiotics. In: Sanchez S, Demain AL (eds) Antibiotics: current innovations and future trends. Caister Academic Press, Norfolk, UK, pp 1–18. ISBN 978-1-908230-54-6
Bentley SD, Chater KF, Cerdeño-Tárraga AM et al (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417:141–147. doi:10.1038/417141a
Bérdy J (2012) Thoughts and facts about antibiotics: where we are now and where we are heading. J Antibiot 65:385–395. doi:10.1038/ja.2012.27
Bérdy J (2015) Microorganisms producing antibiotics. In: Sanchez S, Demain AL (eds) Antibiotics: current innovations and future trends. Caister Academic Press, Norfolk, UK, pp 49–64. ISBN 978-1-908230-54-6
Billeter M, Zervos MJ, Chen AY et al (2008) Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic. Clin Infect Dis 46:577–583. doi:10.1086/526772
Bister B, Bischoff D, Ströbele M, Riedlinger J, Reicke A et al (2004) Abyssomicin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew Chem Int Ed Engl 43:2574–2576. doi:10.1002/anie.200353160
Blin K, Medema MH, Kazempour D et al (2013) antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res 41:W204–W212. doi:10.1093/nar/gkt449
Boakes S, Appleyard AN, Cortés J, Dawson MJ (2010) Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362. J Antibiot (Tokyo) 63:351–358. doi:10.1038/ja.2010.48
Boucher HW, Talbot GH, Benjamin DK Jr et al (2013) 10 × ′20 Progress–development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 56:1685–1694. doi:10.1093/cid/cit152
Brahmkshatriya PP, Brahmkshatriya PS (2013) Natural products. Terpenes: chemistry, biological role, and therapeutic applications. In: Ramawat KG, Mérillon J-M (eds) Natural products: phytochemistry, botany and metabolism of alkaloids, phenolics and terpenes. Springer, Berlin, pp 2665–91. doi:10.1007/978-3-642-22144-6
Brakhage A (2013) Regulation of fungal secondary metabolism. Nat Rev Microbiol 11:21–32. doi:10.1038/nrmicro2916
Buchanan GO, Williams PG, Feling RH, Kauffman CA, Jensen PR, Fenical W (2005) Sporolides A and B: structurally unprecedented halogenated macrolides from the marine actinomycete Salinispora tropica. Org Lett 7:2731–2734. doi:10.1021/ol050901i
Butler MS, Blaskovich MA, Cooper M (2013) Antibiotics in the clinical pipeline in 2013. J Antibiot 66:571–591. doi:10.1038/ja.2013.86
Caffrey P, Bevitt DJ, Staunton J et al (1992) Identification of DEBS 1, DEBS 2 and DEBS 3 the multienzyme polypeptides of the erythromycin-producing polyketide synthase from Saccharopolyspora erythraea. FEBS Lett 304:225–228. doi:10.1016/0014-5793(92)80624-P
Cane DE, Ikeda H (2012) Exploration and mining of the bacterial terpenome. Acc Chem Res 45:463–472. doi:10.1021/ar200198d
Castanheira M, Sader HS, Farrell DJ et al (2012) Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant S. aureus carrying various staphylococcal cassette chromosome mec types. Antimicrob Agents Chemother 56:4779–4785. doi:10.1128/AAC.00817-12
Chang FY, Brady SF (2013) Discovery of indolotryptoline antiproliferative by homology-guided metagenomic screening. Proc Natl Acad Sci U S A 110:2478–2483. doi:10.1073/pnas.1218073110
Chatterjee C, Paul M, Xie L et al (2005) Biosynthesis and mode of action of lantibiotics. Chem Rev 105:633–684. doi:10.1021/cr030105v
Chen J-S, Wang Y-X, Shao L et al (2013) Functional identification of the gene encoding the enzyme involved in mannosylation in ramoplanin biosynthesis in Actinoplanes sp. Biotechnol Lett 35:1501–1508. doi:10.1007/s10529-013-1233-3
Chen P, Qi F, Novak J et al (1999) The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred. Appl Environ Microbiol 65:1356–1360
Christianson DW (2006) Structural biology and chemistry of the terpenoid cyclases. Chem Rev 106:3412–3442. doi:10.1021/cr050286w
Clardy J, Fischbach MA, Walsh CT (2006) New antibiotics from bacterial natural products. Nat Biotechnol 24:1541–1550. doi:10.1038/nbt1266
Collins L, Franzblau SG (1997) Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41:1004–1009
Crowther GS, Baines SD, Todhunter SL et al (2013) Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection. J Antimicrob Chemother 68:168–176. doi:10.1093/jac/dks359
Cudic P, Behenna D, Kranz J et al (2002) Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin. Chem Biol 9:897–906
D’Amato RF, Isenberg HD, McKinley GA et al (1988) Novel application of video image processing to biochemical and antimicrobial susceptibility testing. J Clin Microbiol 26:1492–1495
Dairi T (2005) Studies on biosynthetic genes and enzymes of isoprenoids produced by Actinomycetes. J Antibiot 58:227–243. doi:10.1038/ja.2005.27
Daniel F (2004) Plant species coexistence and dispersion of seed traits in a grassland. Ecography 27:218–224
Demain AL, Sanchez S (2015) The need for new antibiotics. In: Sanchez S, Demain AL (eds) Antibiotics: current innovations and future trends. Caister Academic Press, Norfolk, UK, pp 65–82. ISBN 978-1-908230-54-6
Derewacz DK, Goodwin CR, McNees R et al (2013) Antimicrobial drug resistance affects broad changes in metabolomic phenotype in addition to secondary metabolism. Proc Natl Acad USA 110:2336–2341. doi:10.1037/pnas.1218524110
de Souza Mendes C, de Antunes Souza A (2013) Pipeline of known chemical classes of antibiotics. Antibiotics 2:500–534. doi:10.3390/antibiotics2040500
Donadio S, Monciardini P, Sosio M (2007) Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics. Nat Prod Rep 24:1073–1109. doi:10.1039/B514050C
Donia MS, Cimermancic P, Schulze C et al (2014) A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158:1402–1414. doi:10.1016/j.cell.2014.08.032
Draper MP, Weir S, Macone A et al (2014) Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. Antimicrob Agents Chemother 58:1279–1283. doi:10.1128/AAC.01066-13
Dreyfuss MM, Chapela IH (1994) Potential of fungi in the discovery of novel, low-molecular weight pharmaceuticals. In: Gullo VP (ed) The discovery of natural products with therapeutic potential. Butterworth-Heinemann, London, UK, pp 49–80
Ebel R (2010) Terpenes from marine-derived fungi. Mar Drugs 8:2340–2368. doi:10.3390/md8082340
Fabbretti A, Gualerzi CO, Brandi L (2011) How to cope with the quest for new antibiotics. FEBS Lett 585(11):1673–1681. doi:10.1016/j.febslet.2011.04.029
Feng Z, Kim JH, Bardy SF (2010) Fluostatins produced by the heterologous expression of a TAR reassembled environmental DNA derived type II PKS gene cluster. J Am Chem Soc 132:11902–11903. doi:10.1021/ja104550p
Feng Z, Kallifidas D, Brady SF (2011) Functional analysis of environmental DNA-derived type II polyketide synthases reveals structural diverse secondary metabolites. Proc Nat Acad Sci USA 108:12629–12634. doi:10.1073/pnas.1103921108
Fischbach MA, Walsh CT (2006) Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 106:3468–3496. doi:10.1021/cr0503097
Fleischmann RD, Adams MD, White O et al (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496–512. doi:10.1126/science.7542800
Forschner-Dancause S, LaPlante K, Smith DC et al (2012) Going deep for drug discovery: an ocean to bedside approach to explore sub-seafloor microbes for the next generation of antibiotics. Med Health RI 95:292–293
Gene H, Hur G, Vickerya C, Burkarta MD (2012) Explorations of catalytic domains in non-ribosomal peptide synthetase enzymology. Nat Prod Rep 29:1074–1098. doi:10.1039/C2NP20025B
Genilloud O (2014) The re-emerging role of microbial natural products in antibiotic discovery. A van Leeuw 106:173–188. doi:10.1007/s10482-014-0204-6
Gingery D (2013) Antibiotic development: as FDA’s QIDP list grows longer, will firms GAIN less? The Pink Sheet. Article 00130923008
Goto Y, Li B, Claesen J et al (2010) Discovery of unique lanthionine synthetase reveals new mechanistic and evolutionary insights. PLoS Biol 8:e1000339. doi:10.1371/journal.pbio.1000339
Gourdeau H, McAlpine JB, Ranger M et al (2008) Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand. Cancer Chemother Pharmacol 61:911–921. doi:10.1007/s00280-008-0848-x
Grindberg RV, Ishoey T, Brinza D et al (2011) Single cell genome amplification accelerates identification of the apratoxin biosynthetic pathway from a complex microbial assemblage. PLoS ONE 6:e18565. doi:10.1371/journal.pone.0018565
Gulder TAM, Moore BS (2010) The salinosporamide natural product family: potent 20S proteasome inhibitors as potential cancer chemotherapeutic. Angew Chem Int Ed 49:9346–9367. doi:10.1002/anie.201000728
Gunatilaka AAL (2006) Natural products from plant associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence. J Nat Prod 69:509–526. doi:10.1021/np058128n
Guzman-Trampe S, Rodríguez-Peña K, Espinosa-Gómez A et al (2015) Endophytes as a potential source of new antibiotics. In: Sanchez S, Demain AL (eds) Antibiotics: current innovations and future trends. Caister Academic Press, Norfolk, UK, pp 175–204. ISBN 978-1-908230-54-6
Hamad B (2010) The antibiotics market. Nat Rev Drug Discov 9:675–676. doi:10.1038/nrd3267
Hasper HE, Kramer NE, Smith JL et al (2006) An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313:1636–1637. doi:10.1126/science.1129818
Hegde SS, Okusanya OO, Skinner R et al (2012) Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model. Antimicrob Agents Chemother 56:1578–1583. doi:10.1128/AAC.05382-11
Herold K, Gollmick FA, Groth I, Roth M, Menzel KD, Möllmann U, Gräfe U, Hertweck C (2005) Cervimycin A-D: a polyketide glycoside complex from a cave bacterium can defeat vancomycin resistance. Chemistry-A Eur J 11:5523–5530. doi:10.1002/chem.200500320
Hertweck C, Luzhetskyy A, Rebets Y et al (2007) Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork. Nat Prod Rep 24:162–190. doi:10.1039/B507395M
Hertweck C (2009) The biosynthetic logic of polyketide diversity. Angew Chem Int Ed Engl 48:4688–4716. doi:10.1002/anie.200806121
Hill GB (1991) Spiral gradient endpoint method compared to standard agar dilution for susceptibility testing of anaerobic gram-negative bacilli. J Clin Microbiol 29:975–979
Hillman JD, Novák J, Sagura E et al (1998) Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans. Infect Immun 66:2743–2749
Hoertz AJ, Hamburger JB, Gooden DM et al (2012) Studies on the biosynthesis of the lipo depsipeptide antibiotic Ramoplanin A2. Bioorg Med Chem 20:859–865. doi:10.1016/j.bmc.2011.11.062
Hur G, Vickerya C, Burkarta M (2012) Explorations of catalytic domains in non-ribosomal peptide synthetase enzymology. Nat Prod Rep 29:1074–1098. doi:10.1039/C2NP20025B
Hyatt D, Chen GL, LoCascio P et al (2010) Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics 11:119. doi:10.1186/1471-2105-11-119
Ikeda H, Omura S (1997) Avermectin biosynthesis. Chem Rev 97:2591–2610
Ikeda H, Ishikawa J, Hanamoto A et al (2003) Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol 21:526–531. doi:10.1038/nbt820
Imhoff JF, Labes A, Wiese J (2011) Bio-mining the microbial treasures of the ocean: new natural products. Biotechnol Adv 29:468–482. doi:10.1016/j.biotechadv.2011.03.001
Ito T, Masubuchi M (2014) Dereplication of microbial extracts and related analytical technologies. J Antibiot 67:353–360. doi:10.1038/ja.2014.12
Jensen PR, Fenical W (2005) New natural-product diversity from marine actinomycetes. In: Zhang L, Demain AL (eds) Natural products drug discovery and therapeutic medicine. Humana Press, Totowa, New Jersey, pp 315–328
Junge K, Eiken H, Deming JW (2004) Bacterial activity at −2 to −20 °C in Arctic wintertime sea ice. Appl Environ Microbiol 70:550–557. doi:10.1128/AEM.70.1.550-557.2004
Kansy M, Senner F, Gubernator K (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 41:1007–10010. doi:10.1021/jm970530e
Karpiński TM, Szkaradkiewicz AK (2013) Characteristic of bacteriocines and their application. Polish J Microbiol 62:223–235
Kempter C, Kaiser D, Haag S et al (1997) CDA: calcium-dependet peptide antibiotics from Streptomyces coelicolor A3(2) containing unusual residues. Angew Chem Int Ed 36:498–501. doi:10.1002/anie.199704981
Khosla C, Tang Y, Chen AY et al (2007) Structure and mechanism of the 6-deoxyerythronolide B synthase. Annu Rev Biochem 76:195–221. doi:10.1146/annurev.biochem.76.053105.093515
Kim J, Yi G-S (2012) PKMiner: a database for exploring type II polyketide synthases. BMC Microbiol 12:169. doi:10.1186/1471-2180-12-169
Kim TK, Hewavitharana AK, Shaw PN, Fuerst JA (2006) Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction. Appl Environ Microbiol 72:2118–2125. doi:10.1128/AEM.72.3.2118-2125.2006
Koehn FE (2008) High impact technologies for natural products screening. Prog Drug Res 65:176–210
Krug D, Müller R (2014) Secondary metabolomics: the impact of mass spectrometry-based approaches on the discovery and characterization of microbial natural products. Nat Prod Rep 31:768–783. doi:10.1039/c3np70127a
Kusari S, Hertweck C, Spiteller M (2012) Chemical ecology of endophytic fungi: origins of secondary metabolites. Chem Biol 19:792–798. doi:10.1016/j.chembiol.2012.06.004
Kwon HC, Kauffman CA, Jensen PR, Fenical W (2006) Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus Marinispora. J Am Chem Soc 128:1622–1632. doi:10.1021/ja0558948
Lautru S, Deeth R, Bailey L et al (2005) Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nat Chem Biol 1:265–269. doi:10.1038/nchembio731
Liu G, Chater KF, Chandra G et al (2013) Molecular regulation of antibiotic biosynthesis in streptomyces. Microbiol Mol Biol Rev 77:112–143. doi:10.1128/MMBR.00054-12
Ling LL, Schneider T, Peoples AJ et al (2015) A new antibiotic kills pathogens without detectable resistance. Nature 517:455–459. doi:10.1038/nature14098
Long DD, Aggen JB, Chinn J et al (2008) Exploring the positional attachment of glycopeptide/β-lactam heterodimers. J Antibiot (Tokyo) 61:603–614. doi:10.1038/ja.2008.8
Luo C, Tsementzi D, Kyrpides N et al (2012) Direct comparisons of Illumina vs. Roche 454 sequencing technologies on the same microbial community DNA sample. PLoS ONE 7:e30087. doi:10.1371/journal.pone.0030087
Lynn M, Greene J, Todd AB (2003) The arsenal of antibacterial agents and resistance. Nat Rev Gen 4:442–456. doi:10.1038/nrg1086
Macintyre L, Zhang T, Viegelmann C et al (2014) Metabolomic tools for secondary metabolite discovery from marine microbial symbionts. Mar Drugs 12:3416–3448. doi:10.3390/md12063416
Magi A, Benelli M, Gozzini A et al (2010) Bioinformatics for next generation sequencing data. Genes 1:294–307. doi:10.3390/genes1020294
Mardis ER (2008) Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 9:387–402. doi:10.1146/annurev.genom.9.081307.164359
Martin JF, Liras P (2015) Novel antimicrobial and other bioactive metabolites obtained from silent gene clusters. In: Sanchez S, Demain AL (eds) Antibiotics: current innovations and future trends. Caister Academic Press, Norfolk, UK, pp 275–292. ISBN 978-1-908230-54-6
Mcleod MP, Warren RL, Hsiao WWL (2006) The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. Proc Natl Acad Sci USA 103:15582–15587. doi:10.1073/pnas.0607048103
McDaniel R, Thamchaipenet A, Gustafsson C et al (1999) Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel “‘unnatural’” natural products. Proc Natl Acad Sci USA 96:1846–1851
Meier JL, Burkart MD (2011) Proteomic analysis of polyketide and nonribosomal peptide biosynthesis. Curr Opin Chem Biol 15:48–56. doi:10.1016/j.cbpa.2010.10.021
Mendo S, Faustino NA, Sarmento AC et al (2004) Purification and characterization of a new peptide antibiotic produced by a thermotolerant Bacillus licheniformis strain. Biotechnol Lett 26:115–119
Monciardini P, Iorio M, Maffioli S, Sosio M, Donadio S (2014) Discovering new bioactive molecules from microbial sources. Microb Technol 7:209–220. doi:10.1111/1751-7915.12123
Montecalvo MA (2003) Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother 51 Suppl 3:iii31–iii35. doi:10.1093/jac/dkg274
NCBI (National Center for Biotechnology Information) (2014) Microbial genomes. Complete Prokariotic genome. http://www.ncbi.nlm.nih.gov/genome/browse/. Accessed 03 Nov 2014)
Nett M, Ikeda H, Moore B (2009) Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat Prod Rep 26:1362–1384. doi:10.1039/b817069j
Newman DJ, Gragg GM (2012) Natural products as sources of new drugs over the 30 years from. J Nat Prod 75:311–335. doi:10.1021/np200906s
Noguchi H, Taniguchi T, Itoh T (2008) MetaGeneAnnotator: detecting sprecies-specific patterns of ribosomal binding site for precise gene prediction in anonymous prokaryotic and phage genomes. DNA Res 15:387–396. doi:10.1093/dnares/dsn027
Nováková J, Farkašovský M (2013) Bioprospecting microbial metagenome for natural products. Biologia 68:1079–1086. doi:10.2478/s11756-013-0246-7
Ochi K, Hosaka T (2013) New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters. Appl Microbiol Biotechnol 97:87–98. doi:10.1007/s00253-012-4551-9
Oh DC, Williams PG, Kauffman CA et al (2006) Cyanosporasides A and B, chloro- and cyano-cyclopenta[a]indene glycosides from the marine actinomycete Salinispora pacifica. Org Lett 8:1021–1024. doi:10.1021/ol052686b
Ohnishi Y, Ishikawa J, Hara H et al (2008) Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J Bacteriol 190:4050–4060. doi:10.1128/JB.00204-08
Oldach D, Clark K, Schranz J et al (2013) Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia. Antimicrob Agents Chemother 57:2526–2534. doi:10.1128/AAC.00197-13
Oliynyk M, Samborskyy M, Lester JB et al (2007) Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL 23338. Nat Biotechnol 25:447–453. doi:10.1038/nbt1297
Omura S, Ikeda H, Ishikawa J et al (2001) Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci USA 98:12215–12220. doi:10.1073/pnas.211433198
Park H, Thomas M (2015) Antibiotics in the pipeline. In: Sanchez S, Demain AL (eds) Antibiotics: current innovations and future trends. Caister Academic Press, Norfolk, UK, pp 395–416. ISBN 978-1-908230-54-6
Paulsen IT, Press CM, Ravel J et al (2005) Complete genome sequence of the plant commensal Pseudomonas fluorescens Pf-5. Nat Biotechnol 23:873–878. doi:10.1038/nbt1110
Payne DJ, Gwynn MN, Holmes DJ et al (2007) Drugs for bad bugs: confronting the challenges of antibacterial drug discovery. Nat Rev Drug Discov 6:29–40. doi:10.1038/nrd2201
Pelaez F, Genilloud O (2003) Discovering new drugs from microbial natural products. In: Barredo JL (ed) Microorganisms for health care, foods and enzyme production. Research Signpost Trivandrum, India, pp 1–22
Petersen JM, Zielinski FU, Pape T et al (2011) Hydrogen is an energy source for hydrothermal vent symbioses. Nature 476:176–180. doi:10.1038/nature10325
Pidot SJ, Coyne S, Kloss F, Hertweck C (2014a) Antibiotics from neglected bacterial sources. Int J Med Microbiol 304:14–22. doi:10.1016/j.ijmm.2013.08.011
Pidot S, Ishida K, Cyrulies M, Hertweck C (2014b) Discovery of clostrubin, an exceptional polyphenolic polyketide antibiotic from a strictly anaerobic bacterium. Angew Chem Int Ed Engl 53:7856–7859. doi:10.1002/anie.201402632
Piel J (2009) Metabolites from symbiotic bacteria. Nat Prod Rep 26:338–362. doi:10.1039/b703499g
Piel J (2011) Approaches to capturing and designing biologically active small molecules produced by uncultured microbes. Annu Rev Microbiol 65:431–453. doi:10.1146/annurev-micro-090110-102805
Price PB, Bay RC (2012) Marine bacteria in deep Arctic and Antarctic ice cores: a proxy for evolution in oceans over 300 million generations. Biogeosci Disc 9:6535–6577. doi:10.5194/bg-9-3799-2012
Quail M, Smith M, Coupland P et al (2012) A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequences. BMC Genom 13:341. doi:10.1186/1471-2164-13-341
Radjasa OK, Vaske YM, Navarro G et al (2011) Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associations. Bioorg Med Chem 19:6658–6674. doi:10.1016/j.bmc.2011.07.017
Ramadhar TR, Beemelmanns C, Currie CR et al (2014) Bacterial symbionts in agricultural systems provide a streategic source for antibiotic discovery. J Antibiot 67:53–58. doi:10.1038/ja.2013.77
Sams-Dodd F (2005) Target-based drug discovery: is something wrong? Drug Discov Today 10:139–147. doi:10.1016/S1359-6446(04)03316-1
Scheffler RJ, Colmer S, Tynan H et al (2013) Antimicrobials, drug discovery, and genome mining. Appl Microbiol Biotechnol 97:969–978. doi:10.1007/s00253-012-4609-8
Schulz B, Boyle C, Draeger S, Rommert AK, Krohn K (2002) Endophytic fungi: a source of novel biologically active secondary metabolites. Mycol Res 106:996–1004. doi:10.1017/S0953756202006342
Schulz B, Boyle C (2005) The endophytic continuum. Mycol Res 109:661–686. doi:10.1017/S095375620500273X
Sheridan C (2006) Antibiotics au naturel. Nat Biotechnol 24:1494–1496. doi:10.1038/nbt1206-1494
Singh SB, Palaez F (2008) Biodiversity, chemical diversity and drug discovery. Progr Drug Res 65:143–174
Smith L, Hasper H, Breukink E et al (2008) Elucidation of the antimicrobial mechanism of mutacin 1140. Biochemistry 47:3308–3314. doi:10.1021/bi701262z
Soria-Mercado IE, Prieto-Davo A, Jensen PR et al (2005) Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod 68:904–910. doi:10.1021/np058011z
Steinmeyer A (2006) To hit-to-lead process at shering AG: strategic aspects. ChemMedChem 1:31–36. doi:10.1002/cmdc.200500031
Stepanauskas R (2012) Single cell genomics: an individual look at microbes. Curr Opin Microbiol 15(5):613–620. doi:10.1016/j.mib.2012.09.001
Strieker M, Tanović A, Marahiel MA (2010) Nonribosomal peptide synthetases: structures and dynamics. Curr Opin Struct Biol 20:234–240. doi:10.1016/j.sbi.2010.01.009
Sutcliffe J, O’Brien W, Fyfe C et al (2013) Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens. Antimicrob Agents Chemother 57:5548–5558. doi:10.1128/AAC.01288-13
Szu P-H, Govindarajan S, Meehan MJ et al (2012) Analysis of the ketosynthase-chain length factor heterodimer from the fredericamycin polyketide synthase. Chem Biol 18:1021–1031. doi:10.1016/j.chembiol.2011.07.015.Analysis
Tan RX, Zou WX (2001) Endophytes: a rich source of functional metabolites. Nat Prod Rep 18:448–459. doi:10.1039/B100918O
Taylor WT (2013) Alternative natural sources for a new generation of antibacterial agents. Int J Antimicrob Ag 42:195–201. doi:10.1016/j.ijantimicag.2013.05.004
Tetzlaff CN, You Z, Cane DE et al (2006) A gene cluster for biosynthesis of the sesquiterpenoid antibiotic pentalenolactone in Streptomyces avermitilis. Biochemistry 45:6179–6186. doi:10.1021/bi060419n
Tibrewal N, Tang Y (2014) Biocatalysts for natural product biosynthesis. Annu Rev Chem Biomol Eng 5:347–366. doi:10.1146/annurev-chembioeng-060713-040008
Torrice M (2013) Antibacterial boom and bust. Chem Eng News 91(36):34–37. doi:10.1021/cen-09136-cover3
Udwary DW, Zeigler L, Asolkar RN et al (2007) Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Oroc Natl Acad Sci 104:10376–10381. doi:10.1073/pnas.0700962104
UNEP, Convention on Biological Diversity (2000) Conference of the parties to the convention on biological diversity. Progress report on the implementation of the programmes of work on the biological diversity of inland water ecosystems, marine and coastal biological diversity, and forest biological diversity (UNEP/CBD/COP/5/INF/7)
Walkty A, Adam H, Baxter M et al (2014) In vitro activity of plazomicin against 5,015 Gram-negative and Gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011–2012. Antimicrob Agents Chemother 58(5):2554–2563. doi:10.1128/AAC.02744-13
Walsh CT, Wencewitz TA (2014) Prospects for new antibiotics: a molecule-centered perspective. J Antibiot 67:7–22. doi:10.1038/ja.2013.49
Wang D, Bodovitz S (2010) Single cell analysis: the new frontier in ‘omics’. Trends Biotechnol 28:281–290. doi:10.1016/j.tibtech.2010.03.002
Wang J, Soisson SM, Young K et al (2006) Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441:358–361. doi:10.1038/nature04784
Weiss C, Eisner T (1998) Partnerships for value-added through bioprospecting. Technol Soc 20:481–498. doi:10.1016/S0160-791X(98)00029-3
Wenzel SC, Müller R (2009) The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat Prod Rep 26:1385–1407. doi:10.1039/b817073h
WHO (2011) Tackling antibiotic resistance from a food safety perspective in Europe. WHO Regional Office for Europe, Copenhagen
Willey JM, van der Donk WA (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61:477–501. doi:10.1146/annurev.micro.61.080706.093501
Williams PG, Buchanan GO, Feling RH et al (2005) New cytotoxic salinosporamides from the marine Actinomycete Salinispora tropica. J Org Chem 70:6196–6203. doi:10.1021/jo050511+
Winter JM, Behnken S, Hertweck C (2011) Genomics-inspired discovery of natural products. Curr Opin Chem Biol 15:22–31. doi:10.1016/j.cbpa.10.020
Wright G (2014) Something old, something new: revisiting natural products in antibiotic drug discovery. Can J Microbiol 60:147–154. doi:10.1139/cjm-2014-0063
Wong FT, Khosla C (2012) Combinatorial biosynthesis of polyketides—a perspective. Curr Opin Chem Biol 16:117–123. doi:10.1016/j.cbpa.2012.01.018
You Z, Omura S, Ikeda H, Canea DE (2007) Pentalenolactone biosynthesis. Molecular cloning and assignment of biochemical function to PtlF, a short-chain dehydrogenase from Streptomyces avermitilis, and identification of a new biosynthetic intermediate. Arch Biochem Biophys 459(2):233–240. doi:10.1016/j.abb.2006.11.016
Yu D, Xu F, Zeng J et al (2012) Type III polyketide synthases in natural product biosynthesis. IUBMB Life 64:285–295. doi:10.1002/iub.1005
Zhanel GG, Lawson CD, Adam H et al (2013) Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. Drugs 73:159–177. doi:10.1007/s40265-013-0013-7
Zhao B, Lin X, Lei L et al (2008) Biosynthesis of the sesquiterpene antibiotic albaflavenone in Streptomyces coelicolor A3(2). J Biol Chem 283:8183–8189. doi:10.1074/jbc.M710421200
Zhao J, Sun W, Shan T et al (2012) Antimicrobial metabolites from the endophytic fungus Gliomastix murorum Ppf8 associated with the medicinal plant Paris polyphylla var. yunnanensis. J Med Plants Res 6:2100–2104. doi:10.5897/JMPR11.893
Zhao J, Zhou L, Wang J et al (2010) Endophytic fungi for producing bioactive compounds originally from their host plants. In: Méndez-Vilas A (ed) Current research technology and educstion topics in applied microbiology and microbial biotechnology. Formatex Research Center, Badajos, pp 567–576
Zengler K, Paradkar A, Keller M (2005) New methods to access microbial diversity for small molecule discovery. In: Zhang L, Demain AL (eds) Natural products drug discovery and therapeutic medicine. Humana Press, Totowa, pp 275–293
Zotchev S, Sekurova O, Katz L (2012) Genome-based bioprospecting of microbes for new therapeutics. Curr Opin Biotechnol 23:941–947. doi:10.1016/j.copbio.2012.04.002
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Centeno-Leija, S. et al. (2016). Different Approaches for Searching New Microbial Compounds with Anti-infective Activity. In: Villa, T., Vinas, M. (eds) New Weapons to Control Bacterial Growth. Springer, Cham. https://doi.org/10.1007/978-3-319-28368-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-28368-5_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28366-1
Online ISBN: 978-3-319-28368-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)